An Interview with Dr. Angel Qin: "From Leukemia to ALK+ NSCLC: Finding a New Way to Overcome Drug Resistance"

Editors Note: This interview is by Juhi Kunde, Director of Patient Gateways and Science Marketing at LUNGevity and was orginally posted on their web site on March 5, 2024. Dr. Angel Qin, MD, medical oncologist at the University of Michigan and one of the recipients of our ALK Positive Lung Cancer Research Awards. ALK Positive, Inc. collaborated with LUNGevity to support this very important work with the ALK Positive, Inc / LUNGevity ALK-Positive Lung Cancer Research Awards.

Research, ALK ExpertsKirk SmithMarch 24, 2024Research, Dr. Angel Qin, Gilteritinib